Please assess the completion status of the following clinical trial:

Trial Title: Smoking Cessation in Subjects With Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD).

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Subjects will be current cigarette smokers who have smoked an average of at least 10 cigarettes per day during the past year and during the month prior to the screening visit.~* mild to moderate COPD confirmed by spirometry~* Subjects must have a clinical diagnosis of COPD.~Exclusion Criteria:~* Subjects who have made a serious attempt to quit smoking in the past 3 months.~* Subjects who have been previously randomized in a study that has included varenicline.

- Gender: ALL
- Minimum Age: 35 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- placebo (Type: PLACEBO_COMPARATOR): None
- varenicline (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).